gantenerumab
Another amyloid miss in Alzheimer’s as Roche’s crenezumab fails trial
Phil Taylor
AC Immune, Alzheimer's disease, amyloid, crenezumab, gantenerumab, Genentech, Roche
0 Comment
X
Another amyloid miss in Alzheimer’s as Roche’s crenezumab fails trial
https://pharmaphorum.com/news/another-amyloid-miss-in-alzheimers-as-roches-crenezumab-fails-trial/
Roche starts new four-year trial of Alzheimer’s drug gantenerumab
Phil Taylor
Alzheimer's disease, Biogen, donanemab, Eisai, Eli Lilly, gantenerumab, lecanemab, neurology, Roche
0 Comment
X
Roche starts new four-year trial of Alzheimer’s drug gantenerumab
https://pharmaphorum.com/news/roche-starts-new-four-year-trial-of-alzheimers-drug-gantenerumab/
Roche ‘talking to FDA’ as Alzheimer’s drug moves towards 2022 readout
Phil Taylor
Alzheimer's disease, gantenerumab, neurology, Roche, Ronapreve, Sales and Marketing
0 Comment
X
Roche ‘talking to FDA’ as Alzheimer’s drug moves towards 2022 readout
https://pharmaphorum.com/news/roche-talking-to-fda-as-alzheimers-drug-moves-towards-2022-readout/